A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 146.28
GOOG 965.59
MSFT 71.21
BAC 22.82
FB 155.07

Recently Added

TIF 91.79
SNAP 17.54
UAA 21.20
LSTR 84.25
UDOW 121.32

Gaining Speed

AAPL 146.28
GOOG 965.59
MSFT 71.21
BAC 22.82
FB 155.07

ZIOPHARM (ZIOP) Starts ZIO-201 Phase 2 in Germ Cell Tumors

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced the start of a multicenter, single arm Phase 2 investigator-sponsored study of palifosfamide (ZIO-201) in patients with recurrent metastatic germ cell (testicular and ovarian) tumors who have relapsed on initial platinum-based therapy and high dose chemotherapy, or patients who are not eligible for...

Read More




Get Alerted When News Hits On This Stock - FREE!